The short answer
Review L-5-HTP with your prescriber before combining it with methamphetamine. L-5-HTP affects serotonin, and both product guidance and the medication warning support a precaution, although serotonin syndrome from this exact pair has not been directly demonstrated.
What this answer covers
Oral L-5-hydroxytryptophan, not L-tryptophan, another positional isomer or whole Griffonia seed at an assumed equivalent dose.
- Supplement or preparation
- L-5-HTP
- Medication ingredient
- methamphetamine
Why the combination needs review
Health Canada advises professional review before L-5-HTP is used with serotonergic health products. The methamphetamine label warns about serotonin syndrome with serotonergic agents. It does not specifically name 5-HTP.
The human evidence has limits
A small L-5-HTP study showed variable rises in blood serotonin. A separate serotonin-syndrome case involved 5-HTP with sertraline, multiple other products and exercise. Neither study proves the risk with methamphetamine.
Keep the substances and timing separate
L-5-HTP and L-tryptophan are different supplements. Bring the exact ingredient, amount and complete medication list to your prescriber. There is no established dose gap that prevents serotonin toxicity.
Recognize a potentially urgent reaction
Seek urgent medical care for a combination of agitation or confusion, fever or heavy sweating, rapid heartbeat, and tremor or muscle stiffness. These can be signs of serotonin syndrome, particularly after starting or increasing a serotonergic product.
Evidence and practical considerations
Side effects & toxicity
A conditional serotonergic precaution is supported; exact-pair incidence and causal clinical evidence remain unavailable.
- Exact scope
- Oral L-5-hydroxytryptophan, not L-tryptophan, another positional isomer or whole Griffonia seed at an assumed equivalent dose. with Prescribed oral S-methamphetamine hydrochloride; RxNorm 6816 IN and label section 11 establish active-moiety relationship, not dose or stereoisomer interchangeability.
- Medication form and route
- oral
- Timing or duration
- Dose, pattern of use and preparation matter; no universal protective spacing interval established.
What remains uncertain
- Methamphetamine label names tryptophan but not 5-HTP. Applicability rests on exact L-5-HTP guidance and serotonin biology; sertraline case is indirect and confounded.
Factors that may matter: exact product; other medicines; prescribed dose; baseline cardiovascular or serotonergic risk.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral methamphetamine hydrochloride tablets.
Sections 2.4 and 7.1 identify acidifying agents such as ascorbic acid as lowering levels and alkalinizing agents such as sodium bicarbonate as increasing levels; avoid gastrointestinal and urinary alkalinizing co-use. Sections 5.8 and 7.1 warn about serotonin syndrome with serotonergic agents, specifically including tryptophan and St Johns wort. Section 5.3 calls for blood-pressure and pulse monitoring.
How this applies: RxNorm 6816 IN maps to this SPL, and description confirms active ingredient salt relationship. Applies to prescribed oral S-methamphetamine hydrochloride, not other stimulants or unapproved routes.
Regulatory guidance is not a quantified trial for every named pair. No one-hour supplement spacing instruction. General amphetamine language is explicitly incorporated in this exact methamphetamine product label.
Source 2: official product-monograph guidance
webprod.hc-sc.gc.ca · Source check Sep 10, 2026
Population: Adults using oral L-5-HTP products.
Requires professional consultation with serotonergic health products and advises against use with antidepressants.
How this applies: Provides exact L-5-HTP identity and conditional serotonergic precaution.
Methamphetamine is not an antidepressant; the relevant bridge is serotonergic activity and the exact medication warning, not the antidepressant contraindication itself.
Source 3: original clinical study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 18 depressed patients and comparison groups in a loading assessment.
Serum serotonin rose variably after oral L-5-HTP.
How this applies: Supports only the specific result and preparation described; applicability to prescribed oral methamphetamine is explicitly limited.
Small older uncontrolled treatment study. Serum response does not directly measure brain serotonin or prove toxicity with methamphetamine.
Source 4: original case report
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: One adult with serotonin syndrome, rhabdomyolysis and compartment syndrome.
Authors attributed syndrome to sertraline and 5-HTP interaction.
How this applies: Supports only the specific result and preparation described; applicability to prescribed oral methamphetamine is explicitly limited.
No methamphetamine; substantial polypharmacy and uncertain doses, including cyclobenzaprine. Cannot transfer causality or incidence to the requested pair.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current available claims adjudicated from inspected sources; no clinical review asserted. | |
| Research summary published |
Article revision: 29614d6c639775bb
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.